Solid Biosciences Inc (NASDAQ: SLDB) is having an overwhelmingly rough start to the trading session this morning. While the company reported its Q1 financials after the close yesterday, this has little to do with the declines. Ultimately, the fall in value has to do with the fact that the company’s Phase 1/2 clinical trial has … Read more
Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has been granted Fast Track Designation by the FDA, exciting investors and sending the stock for the top. Today, we’ll talk about: The Fast Track Designation; what we’re seeing … Read more
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is having an incredibly strong start to the trading session this mroning, and for good reason. The company reported its financial results, beating expectations on all accounts. Today, we’ll talk about: The financial results; what we’re seeing from CPRX stock as a result; and what we’ll be watching for ahead. … Read more
Seelos Therapeutics Inc (NASDAQ: SEEL) is having an overwhelmingly positive start to the trading session this morning, and for good reason. The company was initiated by one of the most trusted analyst firms on Wall Street, who has a positive opinion. Today, we’ll talk about: The analyst initiation; what we’re seeing from SEEL stock as … Read more
ARCA Biopharma Inc (NASDAQ: ABIO) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced its financial and operational results for the most recent quarter. Today, we’ll talk about: The results; what we’re seeing from ABIO stock as a result; and what we’ll be watching for … Read more
BioLineRx (NASDAQ: BLRX) is having an incredibly strong start to the trading session this mroning, and for good reason. The comapny announced an FDA approval, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The approval; what we’re seeing from BLRX stock as a result; and what we’ll … Read more
Hemispherx BioPharma, Inc (NYSEAMERICAN: HEB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced an update surrounding the commercialization of its Ampligen product, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The update; what we’re seeing from … Read more
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) is headed up in the market this morning after the company announced that it presented new data. As you could imagine, the data was positive, exciting investors and sending the stock up. Today, we’ll talk about: The data; what we’re seeing from ARPO stock as a result; and what we’ll … Read more
InspireMD Inc (NYSEAMERICAN: NSPR) is having an overwhelmingly strong start to the trading session this moring. However, if you’re looking for a press release or an SEC filing, you’re going to be looking for quite a while. There’s nothing out this morning. In fact, the company hasn’t issued any news in some time. So, what’s … Read more
ARCA Biopharma Inc (NASDAQ: ABIO) is having yet another incredibly strong start to the trading session after yesterday’s tremendous gains. While there are no new press releases or SEC filings this morning, the gains are here fore good reason. Today, we’ll talk about: Why ABIO stock is running for the top; what we’re seeing from … Read more